Trial intelligence / Profile preview

Premedication with Pronase and Simethicone for Mucosal Visualization During Gastroscopy

ChiCTR-IPR-16008913Phase 4Recruiting

Sponsor
Beijing Friendship Hospital
Start
Aug 2016
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in Upper gastrointestinal tract cancer comparing Pronase + simethicone premedication with Lidocaine hydrochloride mucilage premedication (2 arms). Primary endpoints: pathological results and small lesions detection. Started Aug 2016; status: recruiting.

02

Drugs

pronasesimethiconelidocaine
03

Conditions

Upper gastrointestinal tract cancer

Beyond the preview

Go deeper on ChiCTR-IPR-16008913.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008913.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call